CP-944629 (original) (raw)
CP-944629, also known as 5-(3-tert-butyl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-4-(2,4,5-trifluorophenyl)-1,3-oxazole (IUPAC name), is a small molecule that is predicted to block DNA transcription by inhibiting DNA topoisomerase. CP-944629 is thought to have anti-tumor activities. CP-944629 is assumed to be a MAPK14 (mitogen-activated protein kinase 14 (human)) inhibitor and a p38alpha inhibitor.
| Property | Value |
|---|---|
| dbo:abstract | CP-944629, also known as 5-(3-tert-butyl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-4-(2,4,5-trifluorophenyl)-1,3-oxazole (IUPAC name), is a small molecule that is predicted to block DNA transcription by inhibiting DNA topoisomerase. CP-944629 is thought to have anti-tumor activities. CP-944629 is assumed to be a MAPK14 (mitogen-activated protein kinase 14 (human)) inhibitor and a p38alpha inhibitor. (en) |
| dbo:iupacName | 3-tert-Butyl-6-[4-(2,4,5-trifluorophenyl)-1,3-oxazol-5-yl][1,2,4]triazolo[4,3-a]pyridine (en) |
| dbo:thumbnail | wiki-commons:Special:FilePath/CP-944629.svg?width=300 |
| dbo:wikiPageID | 61617816 (xsd:integer) |
| dbo:wikiPageLength | 2729 (xsd:nonNegativeInteger) |
| dbo:wikiPageRevisionID | 1105299410 (xsd:integer) |
| dbo:wikiPageWikiLink | dbr:MAPK14 dbc:Fluoroarenes dbc:Triazolopyridines dbr:Small_molecule dbr:DNA_topoisomerase dbc:Oxazoles dbc:Tert-butyl_compounds dbc:Topoisomerase_inhibitors dbr:Antitumor dbr:DNA_transcription dbr:Tert-butyl |
| dbp:imagefile | CP-944629.svg (en) |
| dbp:pin | 3 (xsd:integer) |
| dbp:wikiPageUsesTemplate | dbt:Chembox dbt:Chembox_Identifiers dbt:Chembox_Properties dbt:Reflist dbt:Cascite dbt:Fdacite |
| dct:subject | dbc:Fluoroarenes dbc:Triazolopyridines dbc:Oxazoles dbc:Tert-butyl_compounds dbc:Topoisomerase_inhibitors |
| rdf:type | owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q11173 dbo:ChemicalCompound |
| rdfs:comment | CP-944629, also known as 5-(3-tert-butyl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-4-(2,4,5-trifluorophenyl)-1,3-oxazole (IUPAC name), is a small molecule that is predicted to block DNA transcription by inhibiting DNA topoisomerase. CP-944629 is thought to have anti-tumor activities. CP-944629 is assumed to be a MAPK14 (mitogen-activated protein kinase 14 (human)) inhibitor and a p38alpha inhibitor. (en) |
| rdfs:label | CP-944629 (en) |
| owl:sameAs | wikidata:CP-944629 https://global.dbpedia.org/id/AmaJt |
| prov:wasDerivedFrom | wikipedia-en:CP-944629?oldid=1105299410&ns=0 |
| foaf:depiction | wiki-commons:Special:FilePath/CP-944629.svg |
| foaf:isPrimaryTopicOf | wikipedia-en:CP-944629 |
| is dbo:wikiPageRedirects of | dbr:C19H15F3N4O |
| is dbo:wikiPageWikiLink of | dbr:C19H15F3N4O |
| is foaf:primaryTopic of | wikipedia-en:CP-944629 |
